Newer multiple sclerosis drugs and disability scores-are key data analyses missing? (Q30943783)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Newer multiple sclerosis drugs and disability scores-are key data analyses missing?	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

retrieved

27 June 2017

title

Newer multiple sclerosis drugs and disability scores-are key data analyses missing? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

retrieved

27 June 2017

main subject

disability

0 references

author

Jagannadha Avasarala

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

author name string

Jagannadha R Avasarala

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

retrieved

27 June 2017

publication date

1 May 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

retrieved

27 June 2017

published in

The Journal of Clinical Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

volume

55

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

page(s)

1218-1220

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

cites work

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Randomized trial of oral teriflunomide for relapsing multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Exploring the origins of grey matter damage in multiple sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Spinal cord gray matter atrophy correlates with multiple sclerosis disability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJCPH.535

retrieved

21 January 2018

Identifiers

DOI

10.1002/JCPH.535

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

Fatcat ID

release_lrkrjaptmjhj7gztd7imq2d2ui

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/lrkrjaptmjhj7gztd7imq2d2ui

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

25939590

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25939590

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25939590%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30943783&oldid=1964000220"